Leidos price target cut to $153.27 by analysts
A 12-month price target for Leidos Holdings was cut to $153.27, implying higher upside versus the current stock price.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.
News Feed
2 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
Affiliated Managers Group, Goldman Sachs, Vaxcyte: Analysts revise ratings
Wall Street securities analysts revised their ratings and price targets on several US-listed companies, including Affiliated Managers Group, Goldman Sachs and Vaxcyte.